Supplementary data.docx (218.7 kB)

Supplementary data: Quantification of infliximab and adalimumab in human plasma by a liquid chromatography tandem mass spectrometry kit and comparison with two ELISA methods

dataset

posted on 2022-06-23, 10:12 authored by Camille Tron, Florian Lemaitre, Pauline Bros, Claire Goulvestre, Benedicte Franck, Nicolas Mouton, Sandrine Bagnos, Romain Coriat, Nihel Khoudour, Dorothee Lebert, Benoit Blanchet

Tables S1 and S2, and Figure S1

History

Usage metrics

Keywords

adalimumab ELISA infliximab LC-MS/MS therapeutic drug monitoring

Licence

CC BY-NC-ND 4.0

Supplementary data: Quantification of infliximab and adalimumab in human plasma by a liquid chromatography tandem mass spectrometry kit and comparison with two ELISA methods

History

Usage metrics

Categories

Keywords

Licence

Exports